Drug Repurposing in Non-Small Cell Lung Carcinoma: Old Solutions for New Problems

Lung cancer is the second most common cancer and the leading cause of cancer-related deaths in 2022. The majority (80%) of lung cancer cases belong to the non-small cell lung carcinoma (NSCLC) subtype. Despite the increased screening efforts, the median five-year survival of metastatic NSCLC remains...

Descripción completa

Detalles Bibliográficos
Autores principales: Doumat, George, Daher, Darine, Zerdan, Morgan Bou, Nasra, Nasri, Bahmad, Hisham F., Recine, Monica, Poppiti, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9858415/
https://www.ncbi.nlm.nih.gov/pubmed/36661704
http://dx.doi.org/10.3390/curroncol30010055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9858415/
https://www.ncbi.nlm.nih.gov/pubmed/36661704
http://dx.doi.org/10.3390/curroncol30010055

Ejemplares similares